CareMax (NASDAQ:CMAX) reported quarterly losses of $(9.86) per share which missed the analyst consensus estimate of $(6.86) by 43.73 percent. This is a 134.76 percent decrease over losses of $(4.20) per share from the same period last year. The company reported quarterly sales of $198.627 million which missed the analyst consensus estimate of $206.928 million by 4.01 percent. This is a 11.50 percent decrease over sales of $224.440 million the same period last year.
Reported Friday, CareMax Q2 2024 Adj. EPS $(9.86) Misses $(6.86) Estimate, Sales $198.627M Miss $206.928M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.